A vaccine for covid-19 could be rolled out before the end of the year. But a worrying rise in mistrust of vaccines threatens its effectiveness. Now & Next is a series from The Economist Films:
Further content:
Find The Economist’s most recent coverage of covid-19 here:
Sign up to The Economist’s daily newsletter to keep up to date with our latest covid-19 analysis:
The immense promise of the new covid-19 vaccine, and the challenges still to come:
Why an effective covid-19 vaccine is a turning point in the pandemic:
Read more about Pfizer’s and BioNTech’s vaccine:
A second, better, vaccine against covid-19 arrives—read about Moderna’s vaccine:
Rich countries have grabbed half of projected covid-19 vaccine supply:
Daily chart: One in three people want preferential access to a covid-19 vaccine:
How pandemic fears are boosting demand for trustworthy news:
Super fast tests for covid-19 are coming:
How the quest for a vaccine could restore faith in big pharma:
